| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 28/06/2023 | 12:15 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 22/06/2023 | 12:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 20/06/2023 | 12:02 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 12/05/2023 | 22:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 09/05/2023 | 12:01 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 20/04/2023 | 12:05 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 10/04/2023 | 23:16 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 05/04/2023 | 23:28 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 14/03/2023 | 21:03 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 07/03/2023 | 23:13 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 03/03/2023 | 15:11 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 13/02/2023 | 19:53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 23/01/2023 | 22:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 29/11/2022 | 17:44 | Edgar (US Regulatory) | Sec Staff Action/letter (sec Staff) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 10/11/2022 | 22:00 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 31/10/2022 | 14:00 | GlobeNewswire Inc. | Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on F | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 27/10/2022 | 21:33 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 18/10/2022 | 23:07 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 31/08/2022 | 05:21 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 17/08/2022 | 15:00 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North Africa | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 16/08/2022 | 15:00 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers (PBMs) For ZTlido® (lidocaine topica | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 07/07/2022 | 15:30 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc. | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 05/07/2022 | 20:04 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 14/06/2022 | 16:33 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US. | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 07/06/2022 | 14:45 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 03/06/2022 | 15:00 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 18/05/2022 | 15:30 | GlobeNewswire Inc. | Scilex, a Sorrento Company, Announces Initiation of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 in Subjects with Acute Low Back Pain | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 16/05/2022 | 15:00 | GlobeNewswire Inc. | Scilex Holding Company, a Sorrento Company, and Vickers Vantage Corp. I announced today the filing of a Registration Statement on Form S-4 with the Securities and Exchange Commission relating to the previously announced proposed business combination betwee | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 11/05/2022 | 15:00 | GlobeNewswire Inc. | Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for Fibromyalgia | NASDAQ:VCKA | Vickers Vantage Corporation I |
| 06/05/2022 | 02:05 | GlobeNewswire Inc. | Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting | NASDAQ:VCKA | Vickers Vantage Corporation I |